Cancer patients get chance to continue promising treatment in Safety-Focused Follow-Up study
NCT ID NCT07415031
Summary
This study allows cancer patients who benefited from adagrasib treatment in previous trials to continue receiving the medication while researchers monitor long-term safety. The trial focuses on people with advanced solid tumors including lung and colorectal cancers who are already receiving clinical benefit from the drug. Researchers will track side effects and safety outcomes to better understand the treatment's long-term profile.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.